Ipratropium Bromide Eg

Ipratropium Bromide, the active ingredient in Ipratropium Bromide Eg, is an anticholinergic (muscarinic antagonist) presented as a nasal spray for nasal use. It relieves nasal congestion associated with allergic rhinitis, the common cold, and vasomotor rhinitis.

GNH USA supplies Ipratropium Bromide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for import and distribution. Its global network ensures reliable delivery timelines and compliance with local pharmacopeial requirements.

Ipratropium Bromide is a nasal anticholinergic indicated for the relief of nasal congestion by blocking muscarinic receptors in the nasal mucosa, thereby decreasing secretions and vasodilation.

Allergic rhinitis: reduces nasal congestion, rhinorrhea and sneezing, improving breathing comfort in patients with seasonal or perennial allergies. Common cold: alleviates nasal blockage and excess secretions, helping patients experience easier airflow during viral upper respiratory infections. Vasomotor rhinitis: improves nasal airflow and decreases watery discharge in non‑allergic, stimulus‑induced nasal congestion.

Ipratropium Bromide may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning - Dryness of nasal passages - Unpleasant taste - Sneezing

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Nasal ulceration or epistaxis - Paradoxical bronchospasm

Use Ipratropium Bromide only as prescribed and observe the following precautions. - Indication: Use only for nasal congestion as directed. - Hypersensitivity: Discontinue if signs of allergic reaction appear. - Glaucoma: Use with caution in patients with narrow‑angle glaucoma. - Urinary retention: Avoid in patients with prostatic hypertrophy or urinary retention. - Pregnancy: Safety not established; weigh benefits and risks. - Store at room temperature: Keep in original container, protect from moisture and direct sunlight.

Ipratropium Bromide can interact with other medications; monitor the following.

Major Interactions (Avoid): - Concurrent use with other anticholinergic nasal sprays may increase anticholinergic load and risk of dryness. - Use with MAO inhibitors is not recommended due to potential additive effects on autonomic tone.

Moderate Interactions (Monitor Closely): - Co‑administration with antihistamines may enhance nasal dryness. - Combined use with ophthalmic anticholinergics may increase systemic exposure. - Use with drugs that prolong QT interval should be monitored for cardiac effects.